Amgen, one of the largest biotechnology companies in the world, is doubling down on its investment into a Durham health data startup called NoviSci. NoviSci, founded by two Duke University professors, builds statistical software that companies use to evaluate the effectiveness of drugs in patients.
Genentech, a member of the Roche Group, will apply Ribometrix’s discovery platform to discover, develop, and commercialize small molecule drug candidates against RNA targets, through a collaboration that could generate more than $1 billion for the Durham, NC-based developer of RNA-based small molecule therapeutics.
Durham startup 410 Medical has received U.S. Food and Drug Administration (FDA) 510(k) Clearance for its LifeFlow PLUS Blood and Fluid Infuser (LifeFlow PLUS).
Categories: 410 Medical
Frances S. Ligler, Ross Lampe Distinguished Professor in the UNC/NC State Joint Department of Biomedical Engineering, has been recognized by the National Academy of Engineering (NAE) with its Simon Ramo Founders Award.
Categories: Advisory Board News
Altis Biosystems, a company co-founded by BME Associate Professor Scott Magness and former chair Dr. Nancy Allbritton, recently announced completion of a $3.1 million seed investment led by VentureSouth.
Categories: Altis Biosystems